Other Headlines

Former Trade Desk pro from Siemens joins the DOTmed 100 company.
On-pump and off-pump bypass surgery yield similar results, reports the Harvard Heart Letter.
The Institute of Cancer Research has found that women with breast cancer had more manageable side effects when their radiotherapy was delivered in larger - but fewer - doses.
Research on traumatic brain injury will be used to determine faster treatment, safer vehicles.
The Canadian maker of high-end interventional MR suites acquires a prototype neurosurgery robot designed with aerospace technology in exchange for 1.6 million shares.

Have News for Us?

Submit your news on the industry, people, or companies.

Forward to a Friend

More Industry Headlines

New Research Study Will Use fMRIs to Examine Soldiers' TBIs Research on traumatic brain injury will be used to determine faster treatment, safer vehicles.

Congress Submits Bill to Repeal Antitrust Exemption Reform measure would end exemption for health care, medical malpractice insurance.

FDA Issues Guidance on Facilitating Medical Device Clinical Trials Agency suggests statistical methods for cost and streamlining.

White House to Convene Health Meeting President Obama promised a bipartisan event Feb. 25.

Las Vegas Spine Surgeon Pleads Guilty to Misprision of Felony A federal case review from the pages of DOTmed Business News.

Philips Inks Three-Year Deal With SunCrest Philips' telemedicine division inked a three-year deal with the Sun Belt home care system SunCrest Healthcare, Inc.

HHS Highlights Health Care Investments in New Budget Budget includes health IT, research, public health measures.

Colorado Physicians Group Settles With FTC Over Alleged Price-Fixing Group accused of anti-competitive tactics against health insurers.

FDA Wants $4 Billion to Overhaul Medical Device, Food Safety Monitoring The injections of new cash could help establish a registry for medical devices and create over 1,000 new jobs.

NIH Discusses Dose Monitoring Program DOTmed News spoke with Dr. David Bluemke of the National Institutes of Health about the new program to require radiation dose monitoring on all equipment purchased by the NIH's Clinical Center.

AdvaMed code
of ethics
sets boundaries
in industry/physician
interactions

Independent Survey Indicates Med Tech Companies Have Broad Support for AdvaMed Code of Ethics

by Astrid Fiano, DOTmed News Writer
Michael A. Mussallem, chairman and CEO, Edwards Lifesciences, and chairman of the Advanced Medical Technology Association's (AdvaMed) Board of Directors, has announced a new report by PricewaterhouseCoopers LLP in consultation with AdvaMed, which finds the medical device industry has been quick to adopt and implement the association's Code of Ethics. According to an AdvaMed press release, the survey has 90 percent of respondents reporting policies in place that address all provisions of the AdvaMed Code of Ethics.

"Preserving ethical interactions between medical device companies and their physician partners is essential to a robust medical technology industry, and our member companies and the medical technology industry at-large have embraced the AdvaMed Code of Ethics with enthusiasm," Mussallem said in the press release. "An ethical collaboration between medicine and industry helps to fuel the next wave of medical advancement, ensures the safe and effective use of advanced medical technologies, and broadly benefits patient care."

Mussallem went on to say, "PwC's survey confirms the medical technology industry's strong commitment to acting with integrity and vigorously adhering to the highest ethical standards in interactions with health care professionals. While this new research shows strong adoption of the Code, we will continue working to ensure even broader awareness, adoption and support of the Code across industry and the clinical environment."

The survey, in which thirty-two companies participate, showed that close to twenty-five percent of survey respondents in 2005 had no prior corresponding compliance policies in place, and created a new internal company policy in response to the AdvaMed Code.

In addition, the survey found that top compliance challenges in 2009 for these companies included increased investigations from US Attorneys, the Department of justice or the Office of the Inspector General in the pharma and health care industries; increased activity concerning the Federal Anti-kickback Statute and the Foreign Corrupt Practices Act; increase in the number of state marketing and disclosure laws and pending Sunshine Act legislation; implementing an international compliance program with focus on international customizations/accommodations; an increased scrutiny for off-label promotion.

The top compliance program priorities for these companies in 2009 include sales and marketing compliance review; managing impact of revised industry codes, their implementation and affect on promotional tactics; the Foreign Corrupt Practices Act & similar Anti-bribery/Anti-corruption laws; and data privacy.

Based on a press release by AdvaMed, and the PricewaterhouseCoopers Survey Report.



Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

Please Send us your Comments.

Printable Story
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2010 DOTmed.com, Inc.
ALL RIGHTS RESERVED